A Normative Model of Serum Inhibin B in Young Males
- PMID: 27077369
- PMCID: PMC4831823
- DOI: 10.1371/journal.pone.0153843
A Normative Model of Serum Inhibin B in Young Males
Abstract
Inhibin B has been identified as a potential marker of Sertoli cell function in males. The aim of this study is to produce a normative model of serum inhibin B in males from birth to seventeen years. We used a well-defined search strategy to identify studies containing data that can contribute to a larger approximation of the healthy population. We combined data from four published studies (n = 709) and derived an internally validated model with high goodness-of-fit and normally distributed residuals. Our results show that inhibin B increases following birth to a post-natal peak of 270 pg/mL (IQR 210-335 pg/mL) and then decreases during childhood followed by a rise at around 8 years, peaking at a mean 305 pg/mL (IQR 240-445 pg/mL) at around age 17. Following this peak there is a slow decline to the standard mature adult normal range of 170 pg/mL (IQR 125-215 pg/mL). This normative model suggests that 35% of the variation in Inhibin B levels in young males is due to age alone, provides an age-specific reference range for inhibin B in the young healthy male population, and will be a powerful tool in evaluating the potential of inhibin B as a marker of Sertoli cell function in pre-pubertal boys.
Conflict of interest statement
Figures
Similar articles
-
Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men.J Clin Endocrinol Metab. 1998 Feb;83(2):675-81. doi: 10.1210/jcem.83.2.4603. J Clin Endocrinol Metab. 1998. PMID: 9467591
-
Sexual dimorphism in circulating monomeric and dimeric inhibins in normal boys and girls from birth to puberty.Clin Endocrinol (Oxf). 1999 Oct;51(4):455-60. doi: 10.1046/j.1365-2265.1999.00814.x. Clin Endocrinol (Oxf). 1999. PMID: 10583312
-
Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male.J Clin Endocrinol Metab. 1998 Aug;83(8):2849-54. doi: 10.1210/jcem.83.8.5008. J Clin Endocrinol Metab. 1998. PMID: 9709958
-
Role of inhibins in childhood and puberty.J Pediatr Endocrinol Metab. 2001 Apr;14(4):343-53. doi: 10.1515/jpem.2001.14.4.343. J Pediatr Endocrinol Metab. 2001. PMID: 11327369 Review.
-
Serum inhibin B levels during male childhood and puberty.Mol Cell Endocrinol. 2001 Jun 30;180(1-2):103-7. doi: 10.1016/s0303-7207(01)00520-2. Mol Cell Endocrinol. 2001. PMID: 11451578 Review.
Cited by
-
Molecular insights into Sertoli cell function: how do metabolic disorders in childhood and adolescence affect spermatogonial fate?Nat Commun. 2024 Jul 3;15(1):5582. doi: 10.1038/s41467-024-49765-1. Nat Commun. 2024. PMID: 38961093 Free PMC article. Review.
-
Testicular Sertoli Cell Hormones in Differences in Sex Development.Front Endocrinol (Lausanne). 2022 Jul 14;13:919670. doi: 10.3389/fendo.2022.919670. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909548 Free PMC article. Review.
-
Gonadal Failure in a Male With 3-M Syndrome.JCEM Case Rep. 2024 Jun 6;2(6):luae084. doi: 10.1210/jcemcr/luae084. eCollection 2024 Jun. JCEM Case Rep. 2024. PMID: 38847008 Free PMC article.
-
Cancer treatment in childhood and testicular function: the importance of the somatic environment.Endocr Connect. 2018 Feb;7(2):R69-R87. doi: 10.1530/EC-17-0382. Epub 2018 Jan 19. Endocr Connect. 2018. PMID: 29351905 Free PMC article. Review.
-
Mini-Puberty, Physiological and Disordered: Consequences, and Potential for Therapeutic Replacement.Endocr Rev. 2024 Jul 12;45(4):460-492. doi: 10.1210/endrev/bnae003. Endocr Rev. 2024. PMID: 38436980 Free PMC article. Review.
References
-
- Anderson RA, Sharpe RM. Regulation of inhibin production in the human male and its clinical applications. International journal of andrology. 2000;23(3):136–44. - PubMed
-
- Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. The Journal of clinical endocrinology and metabolism. 1997;82(12):3976–81. 10.1210/jcem.82.12.4449 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources